DeciBio is a niche market research and strategy consulting firm focused on the research tools, global clinical diagnostics, and medical device industries.
While traditional market research and strategy consulting firms shy away from the highly technical nature of our focused industries, we thrive in markets requiring the unique combination of deep technical understanding and business insights.
DeciBio market reports provide clarity for today and insight into tomorrow. Powered by the synthesis of available data, expert interviews and voice-of-customer research, we build rigorous, bottoms-up models for every key segment of the market. Our market reports are sought out by market insiders and outsiders alike for their accuracy, in-depth analysis and insights.
DeciBio Consulting provides tailored consulting services to address your most challenging business issues. Because we live and breathe the clinical diagnostics, research tools and medical device markets, we’re always ready to hit the ground running. Our staff is comprised of passionate, seasoned experts with relevant clinical, research and industry work experience.
Illumina’s Q3 2013 revenues indicate that our aggressive forecast of 20% CAGR for the NGS market over the next 3
The $300M+ U.S. HPV molecular testing market will continue to grow despite increasing HPV vaccine usage By David Cavanaugh --- On Wednesday, the
Fluidigm’s continued SCG revenue growth aligns with our aggressive forecast for the SCG market Fluidigm (NASDAQ:FLDM) recently released their Q3 2013
Our Global Reach
DeciBio has the ability, experience, familiarity, and expertise to conduct large scale research projects and business in nearly every region of the world.